Role of muscarinic receptor anatgonist in primary cilia structure
毒蕈碱受体拮抗剂在初级纤毛结构中的作用
基本信息
- 批准号:10055100
- 负责人:
- 金额:$ 3.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-01 至 2021-12-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylcholineAgonistAlzheimer&aposs DiseaseAnabolismBiochemical ReactionBiologyBlood VesselsCardiovascular DiseasesCell LineCellsCholinergic ReceptorsCiliaDefectDevelopmentDiabetes MellitusDiseaseEnd stage renal failureEndothelial CellsEndotheliumEssential HypertensionExhibitsFunctional disorderFutureGoalsHumanHuman PathologyHypertensionKidneyLeadLengthLiquid substanceMeasuresMechanicsMolecularMusMuscarinic Acetylcholine ReceptorMuscarinicsNeurotransmittersNitric OxideOrganellesPathologyPatientsPhenotypePhysiologicalPlayPolycystic Kidney DiseasesProductionReactionRegulationRenal functionRenal tubule structureResearchRisk FactorsRoleSensoryStimulusStructureSystemTestingTimeUnited StatesVasodilationVasodilator Agentscholinergicciliopathyin vitro testinginterestmutantnovelresponseshear stresstherapeutic target
项目摘要
Abstract:
Primary endothelial cilia are mechanosensory organelles that are projected into the lumen of blood vessels and
kidney tubules. Defects in cilia assembly or function can lead to multiple human pathologies, including
hypertension and Polycystic Kidney Disease (PKD). Acetylcholine, a neurotransmitter, is implicated in essential
hypertension in humans. It has been demonstrated that vascular endothelia require primary cilia to sense and
transmit external mechanical stimuli into internal biochemical reactions. One of these reactions includes the
biosynthesis and release of nitric oxide, which is one of the most potent endogenous vasodilators. Though both
primary cilia and muscarinic acetylcholine receptors play important roles in hypertension, their relationship has
never been explored. To determine the roles of the cholinergic system and mechanosensory cilia, we studied
the effects of acetylcholine receptor modulators on ciliary length and function in wild-type (WT) and mechano-
insensitive cilia mutant endothelial cells (Pkd1−/− and Tg737orpk/orpk). Studies from our lab showed for the first time
that mouse vascular endothelia exhibit muscarinic receptor-type 1, 3 and 5 (AChM1, 3, and 5R), which co-
localizes to primary endothelial cilia. AChM3R activation significantly increases cilia length in cells treated with
AChM3R agonist compared to non-treated cells. Furthermore, the chemosensory function of cilia can alter the
mechanosensory function through changes in sensitivity to fluid-shear stress. We propose that activated ciliary
AChM3R has a functional mechanosensory role in endothelial cells. We propose in the current study that
AChM3R antagonist will have the opposite effect and shorten cilia length. This could also diminish cilia sensory
function in response to NO production.
文摘:
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
"Commentary: Alcohol Consumption Impairs the Ependymal Cilia Motility in the Brain Ventricles".
“评论:饮酒会损害脑室室管膜纤毛运动”。
- DOI:10.29245/2572.942x/2019/2.1250
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Saternos,HannahC;AbouAlaiwi,WissamA
- 通讯作者:AbouAlaiwi,WissamA
Primary Cilia and Calcium Signaling Interactions.
- DOI:10.3390/ijms21197109
- 发表时间:2020-09-26
- 期刊:
- 影响因子:5.6
- 作者:Saternos H;Ley S;AbouAlaiwi W
- 通讯作者:AbouAlaiwi W
Signaling interplay between primary cilia and nitric oxide: A mini review.
- DOI:10.1016/j.niox.2018.08.003
- 发表时间:2018-11-01
- 期刊:
- 影响因子:0
- 作者:Saternos HC;AbouAlaiwi WA
- 通讯作者:AbouAlaiwi WA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wissam Aboualaiwi其他文献
Wissam Aboualaiwi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wissam Aboualaiwi', 18)}}的其他基金
Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease
脑血管内皮纤毛在阿尔茨海默病发病机制和治疗中的作用
- 批准号:
10575082 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
Effect of muscarinic receptor agonist on cilia sensory function and structure
毒蕈碱受体激动剂对纤毛感觉功能和结构的影响
- 批准号:
10025768 - 财政年份:2020
- 资助金额:
$ 3.42万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 3.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 3.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)